Skip to content

Scholar Rock SRRK Price / sales

Discontinued — last reported Q1 '22

Price / sales at other companies

Biogen logo
BiogenBIIB
2.7×+0.7×
PTC Therapeutics logo
PTC TherapeuticsPTCT
6.8×+4.6×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
5.1×-0.4×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
24.8×-26.8×
Arrowhead Research logo
Arrowhead ResearchARWR
14.1×+10.9×
Cytokinetics logo
CytokineticsCYTK
76.7×-171×

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Calculated from Scholar Rock’s reported figures.

Based on the most recent quarter.

The official record: Scholar Rock’s 10-Q, filed May 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's price / sales?
Scholar Rock (SRRK) reported price / sales of 9.6× in Q1 2022.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.